» Articles » PMID: 34509790

COVID-19 Associated Rhino-orbital-cerebral Mucormycosis: An Observational Study from Eastern India, with Special Emphasis on Neurological Spectrum

Abstract

Aims: 1: Describe the epidemiology and determine risk factors for COVID-19 associated mucormycosis. 2: Elaborate the clinical spectrum of Rhino-Orbital-Cerebral Mucormycosis (ROCM), pattern of neuroaxis involvement and it's radiological correlates.

Methods: Observational study. Consecutive, confirmed cases of mucormycosis (N = 55) were included. A case of mucormycosis was defined as one who had clinical and radiological features consistent with mucormycosis along with demonstration of the fungus in tissue via KOH mount/culture/histopathological examination (HPE). Data pertaining to epidemiology, risk factors, clinico-radiological features were analysed using percentage of total cases.

Results: Middle aged, diabetic males with recent COVID-19 infection were most affected. New onset upper jaw toothache was a striking observation in several cases. Among neurological manifestations headache, proptosis, vision loss, extraocular movement restriction; cavernous sinus, meningeal and parenchymal involvement were common. Stroke in ROCM followed a definitive pattern with watershed infarction.

Conclusions: New onset upper jaw toothache and loosening of teeth should prompt an immediate search for mucormycosis in backdrop of diabetic patients with recent COVID-19 disease, aiding earlier diagnosis and treatment initiation. Neuroaxis involvement was characterized by a multitude of features pertaining to involvement of optic nerve, extraocular muscles, meninges, brain parenchyma and internal carotid artery.

Citing Articles

Estimation of the pattern of ocular manifestations, risk factors, and imaging of rhino-orbital-cerebral mucormycosis in COVID-19 patients.

Kaur R, Budhiraja G, Bhumbla U, Kaur M, Sharma V, Gupta P J Family Med Prim Care. 2025; 14(1):259-267.

PMID: 39989522 PMC: 11844987. DOI: 10.4103/jfmpc.jfmpc_1161_24.


Anticoagulation in the management of septic cavernous sinus thrombosis secondary to rhino-orbito-cerebral mucormycosis: A retrospective real-world experience.

Amani K, Shahbazi M, Behkar A, Farahmand G, Ghafouri S, Heydari S Curr J Neurol. 2024; 23(1):44-58.

PMID: 39431225 PMC: 11489632. DOI: 10.18502/cjn.v23i1.16432.


Multicenter and multimodal imaging study reveals rare fundus lesions in patients after SARS-CoV-2 infection.

An G, Lei B, Wang Z, Yang K, Fan D, Li B Sci Rep. 2024; 14(1):14369.

PMID: 38909148 PMC: 11193808. DOI: 10.1038/s41598-024-65216-9.


Clinicoradiological Profile of COVID-19-Associated Rhino-Orbital Cerebral Mucormycosis with a Focus on Computed Tomography: A Clinical Case Series and Review.

Prabhakar A, Bansal S, Vyas S, Bhatia V, Kumar A, Patro S Am J Trop Med Hyg. 2023; 109(3):600-607.

PMID: 37487562 PMC: 10484265. DOI: 10.4269/ajtmh.22-0298.


Central Retinal Artery Occlusion in COVID-Associated Mucormycosis.

Srivastava S, Sarkar P, Ganguly P, Mukherjee D, Ray B, Dubey S J Glob Infect Dis. 2023; 15(2):66-71.

PMID: 37469471 PMC: 10353642. DOI: 10.4103/jgid.jgid_185_22.


References
1.
Mulki R, Masab M, Eiger G, Perloff S . Lethargy and vision loss: successful management of rhinocerebral mucormycosis. BMJ Case Rep. 2016; 2016. PMC: 4904383. DOI: 10.1136/bcr-2016-215855. View

2.
Fanfair R, Benedict K, Bos J, Bennett S, Lo Y, Adebanjo T . Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011. N Engl J Med. 2012; 367(23):2214-25. DOI: 10.1056/NEJMoa1204781. View

3.
Ahmadikia K, Jamal Hashemi S, Khodavaisy S, Getso M, Alijani N, Badali H . The double-edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza-associated mucormycosis versus COVID-19 associated mucormycosis. Mycoses. 2021; 64(8):798-808. PMC: 8013756. DOI: 10.1111/myc.13256. View

4.
Lass-Florl C . The changing face of epidemiology of invasive fungal disease in Europe. Mycoses. 2009; 52(3):197-205. DOI: 10.1111/j.1439-0507.2009.01691.x. View

5.
Brown J . Zygomycosis: an emerging fungal infection. Am J Health Syst Pharm. 2005; 62(24):2593-6. DOI: 10.2146/ajhp050188. View